Oculis’ Post

View organization page for Oculis, graphic

3,960 followers

This week, Riad SHERIF, M.D., Chief Executive Officer of Oculis will participate in the “Derisked Late-stage Candidates for Retinal Disorder” panel discussion at the H.C. Wainwright 4th Annual Ophthalmology Virtual Conference.   Oculis is committed to driving forward it’s late-stage clinical development programs to save sight and improve eye care including both Phase 3 DIAMOND trials with OCS-01 eye drops for diabetic macular edema.   For additional details on our participation, see our press release here: https://bit.ly/3WMXZuR   The Panel is scheduled for August 15, 2024 at 11:00 am ET and a corporate presentation of Oculis will also be made available, on demand, on August 15, 2024 at 7:00am ET.   To access both webcast links, please visit: https://lnkd.in/eKgVER_5   #eyehealth #opthalmology #biotech #biopharma #eyedisease #HCWainwright

  • No alternative text description for this image

To view or add a comment, sign in

Explore topics